Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Expert Opinion on Therapeutic Targets|September 20, 2006
Targeting the CB2 receptor for immune modulationCharles A Lunn, Eva-Pia Reich, Loretta BoberImmunopharmacology and Immunotoxicology|December 14, 2007
Cannabinoid CB(2)-selective inverse agonist protects against antigen-induced bone lossCharles A Lunn, Jay Fine, Alberto Rojas-Triana, et al.Molecular Pharmacology|January 16, 2003
Pharmacological analysis of calcium responses mediated by the human A3 adenosine receptor in monocyte-derived dendritic cells and recombinant cellsJames Fossetta, James Jackson, Gregory Deno, et al.Journal of Lipid Research|February 8, 2011
Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesityHong Lan, Cliff C Cheng, Timothy J Kowalski, et al.ACS Medicinal Chemistry Letters|June 24, 2015
Potent and Selective Amidopyrazole Inhibitors of IRAK4 That Are Efficacious in a Rodent Model of InflammationWilliam T McElroy, Zheng Tan, Ginny Ho, et al.World Journal of Gastroenterology|November 26, 2009
Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokinesMary Ann Cox, James Jackson, Michaela Stanton, et al.PPAR Research|May 7, 2010
Kinetic assessment and therapeutic modulation of metabolic and inflammatory profiles in mice on a high-fat and cholesterol dietLaura W Engstrom, Loretta Bober, Shu-Cheng Chen, et al.Pageof 1